Motley Fool Money cover image

Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos

Motley Fool Money

00:00

Revolutionizing Pharma: New Models vs. Giants

This chapter explores the challenges posed by emerging pharmaceutical business models like GoodRx and Cost Plus Drugs to established companies such as CVS and Walgreens. It also highlights innovative plans for a new manufacturing plant in Dallas which aims to address drug shortages and enhance access to affordable medications.

Play episode from 05:35
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app